...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM webcast 9/12/2018

Based on Sarah's latest update, seems that the Resverlogix slide deck will be posted at the time of the live presentation but the Zenith slide deck will be posted at the time of the archived webcast posting.

"Further to my last response, the Company will post the RVX AMG presentation (PDF) at the commencement of the live presentation, so approximately 1:30 MT today. Zenith’s PDF will go up with the webcast archive by 7 pm MT."

Share
New Message
Please login to post a reply